Search Results - Evelien Moorkens
- Showing 1 - 7 results of 7
-
1
An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry? by Evelien Moorkens, Arnold G. Vulto, Isabelle Huys
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Economic evaluation of biosimilars for reimbursement purposes - what, when, how? by Evelien Moorkens, Hannah Broux, Isabelle Huys, Arnold G. Vulto, Steven Simoens
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape by Evelien Moorkens, Nicolas Meuwissen, Isabelle Huys, Paul Declerck, Arnold G. Vulto, Steven Simoens
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany by Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries? by Yujeong Kim, Hye-Young Kwon, Hye-Young Kwon, Brian Godman, Brian Godman, Brian Godman, Evelien Moorkens, Steven Simoens, SeungJin Bae
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
6
How to balance valuable innovation with affordable access to medicines in Belgium? by Steven Simoens, Khadidja Abdallah, Liese Barbier, Teresa Barcina Lacosta, Alessandra Blonda, Elif Car, Zilke Claessens, Thomas Desmet, Evelien De Sutter, Laurenz Govaerts, Rosanne Janssens, Teodora Lalova, Teodora Lalova, Evelien Moorkens, Robbe Saesen, Robbe Saesen, Elise Schoefs, Yannick Vandenplas, Eline Van Overbeeke, Ciska Verbaanderd, Ciska Verbaanderd, Isabelle Huys
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
7
The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures by Evelien Moorkens, Brian Godman, Brian Godman, Brian Godman, Isabelle Huys, Iris Hoxha, Admir Malaj, Simon Keuerleber, Silvia Stockinger, Sarah Mörtenhuber, Maria Dimitrova, Konstantin Tachkov, Luka Vončina, Vera Vlahović Palčevski, Gnosia Achniotou, Juraj Slabý, Leona Popelková, Kateřina Kohoutová, Dorthe Bartels, Ott Laius, Jaana E. Martikainen, Gisbert W. Selke, Vasileios Kourafalos, Einar Magnússon, Rannveig Einarsdóttir, Roisín Adams, Roberta Joppi, Eleonora Allocati, Arianit Jakupi, Anita Viksna, Ieva Greičiūtė-Kuprijanov, Patricia Vella Bonanno, Vincent Suttorp, Øyvind Melien, Robert Plisko, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Corinne Zara, Vanda Marković-Peković, Nataša Grubiša, Gustaf Befrits, Robert Puckett, Arnold G. Vulto, Arnold G. Vulto
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book